Skip to main content
. Author manuscript; available in PMC: 2018 May 11.
Published in final edited form as: J Surg Oncol. 2017 May 11;115(6):704–710. doi: 10.1002/jso.24570

Table 2. Tumor and treatment characteristics of primary and secondary hepatic metastases treated with IRE (N=77).

Variable (N=77) N (%)
Tumor Size (cm) Median (range) 1.3 (0.5-6)
Lesion Pathology
Colorectal 57 (74)
Hepatocellular 7 (9)
Leiomyosarcoma 5 (6)
Neuroendocrine 4 (5)
Ampullary 3 (4)
Cholangiocarcinoma 1 (1)
Distance to Major Vasculature
< 3mm 55 (71.4)
3-5mm 14 (18.2)
5-10mm 2 (2.6)
>10mm 6 (7.8)
Close to 1st degree bile duct No 53 (68.8)
Yes 24 (31.2)
IRE treatments per Lesion Median (range) 2 (1-7)
Ablation Zone Size (cm) Median (range) 3 (1.5-8)
IRE Combined with Other Procedures 63 (82)
Non-anatomic hepatectomy 50 (64)
Left lateral segmentectomy 10 (13)
Caudate lobectomy 5 (6)
Right lobectomy 2 (3)
Segmentectomy 13 (17)
Cholecystectomy 8 (10)
Microwave ablation 32 (41)
Radiofrequency ablation 2 (3)
Distal pancreatectomy 3 (4)
Partial gastrectomy 1 (1)
Placement of hepatic arterial infusion pump 15 (19)